Blood access is the most important determinant for the continued well-being of an end-stage renal failure patient, maintained on hemodialysis. From the variety of angioaccess techniques available today, the choice of one most suitable for a patient, applied at the appropriate time with an exacting technique may liberate the patient from incessant fear of loss of his "life line". Quinton-Schribner shunt as a prototype of external prosthetic angioaccess devices made life on the artificial kidney possible, but repeated thrombosis, inevitable infection, limitations of activity and threat of accidental dislodgement have severly restricted its usefulness. The internal arteriovenous fistula and its several modifications have almost completely supplanted the use of external prosthetic devices. When the procedure of choice, a direct arterio-venous fistula, is not applicable, an interposed graft of biologic prosthetic origin may be employed. Percutaneous femoral vein catheterization and veno-venous dialysis is an acceptable, indeed a valuable "stop gap" measure.
血管通路是维持血液透析的终末期肾衰竭患者持续良好状态的最重要决定因素。在当今可用的各种血管通路技术中,选择一种最适合患者的技术,并在适当的时候以严格的技术应用,可能会使患者摆脱对其“生命线”丧失的持续恐惧。作为外部人工血管通路装置原型的Quinton-Schribner分流术使人工肾的生活成为可能,但反复血栓形成、不可避免的感染、活动受限以及意外移位的威胁严重限制了其用途。动静脉内瘘及其多种改良方法几乎完全取代了外部人工装置的使用。当首选的直接动静脉内瘘手术不可行时,可以采用生物人工来源的介入性移植物。经皮股静脉插管和静脉-静脉透析是一种可接受的、确实有价值的“权宜之计”措施。